Barbara N Lubash's Net Worth

$709 Million

Estimate Recalculated Feb 29, 2024 05:54PM EST

Who is Barbara N Lubash?

Barbara N Lubash has an estimated net worth of $709 Million. This is based on reported shares across multiple companies, which include INSULET CORP, PHASERX, INC., Flexion Therapeutics Inc, GLAUKOS Corp, Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, NOVACEA INC, GENOMIC HEALTH INC, INTRALASE CORP, Alexza Pharmaceuticals Inc., and HELICOS BIOSCIENCES CORP.

SEC CIK

Barbara N Lubash's CIK is 0001279592

Past Insider Trading and Trends

2014 was Barbara N Lubash's most active year for acquiring shares with 45 total transactions. Barbara N Lubash's most active month to acquire stocks was the month of April. 2014 was Barbara N Lubash's most active year for disposing of shares, totalling 38 transactions. Barbara N Lubash's most active month to dispose stocks was the month of April. 2016 saw Barbara N Lubash paying a total of $12,999,990.00 for 1,449,369 shares, this is the most they've acquired in one year. In 2016 Barbara N Lubash cashed out on 807,291 shares for a total of $819,291.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHASERX, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.36%
341.96K
$2.51
$2,997,419.56
1.94M
May 23
Form 3/A
0
0
Form 3
0
0
No matching records found

NOVACEA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.07M
2.07M
May 15
Form 3
0
0
No matching records found

Inogen Inc (INGN) Snapshot price: $7.505

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-11.28%
-384.69K
$24.30
-$179,534.67
3.03M
Nov 5 - Nov 7
Form 4
-35.10%
-735.77K
1.36M
Jan 6 - Jan 7
Form 4
-100.00%
-7.95K
$30.98
-$246,159.13
0
Jan 5
Form 4/A
-18.22%
-478.05K
2.15M
Dec 18
Form 4
-100.00%
-9.79K
$29.74
-$291,008.84
0
Dec 23
Form 4
-18.22%
-478.05K
2.15M
Dec 18
Form 4
-41.03%
-28.23K
$24.80
-$699,253.17
40.57K
Nov 17 - Nov 19
Form 4
-22.13%
-753.69K
$25.13
-$237,086.41
2.65M
Nov 12 - Nov 14
Form 4
-100.00%
-8.64K
$24.53
-$211,691.35
0
Nov 10
Form 4
+4.31%
4.44K
$24.30
-$179,534.67
107.47K
Nov 5 - Nov 7
Form 4
0
0
Form 4
-100.00%
-1.90K
$20.83
-$39,568.45
0
Oct 9
Form 4
-40.23%
-27.52K
$21.03
-$145,230.72
40.89K
Oct 7 - Oct 8
Form 4
-10.48%
-398.20K
$23.25
-$171,768.04
3.4M
Sep 9
No matching records found

GENOMIC HEALTH INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+142.77%
2.37M
4.02M
Oct 4
Form 3
0
0
No matching records found

INTRALASE CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.09M
2.09M
Oct 13
Form 3
0
0
No matching records found